We invest in early-stage in life science technologies that address significant healthcare problems in poorly served markets. These are opportunities that have the potential to change the societal healthcare equation. Most often, this means the development of products based on biotechnology or pharmaceutical chemistry but we are receptive to opportunities in medical devices, computational biology and genomics.

Rate us and Write a Review

Your Rating for this listing

angry
crying
sleeping
smily
cool
Browse

Your review is recommended to be at least 140 characters long

building Own or work here? Claim Now! Claim Now!

Claim This Listing